Filing Impact
Filing Sentiment
Form Type
4
Fibrogen Inc
Jun 12, 2025
FibroGen Announces 1-for-25 Reverse Stock Split
Aug 11, 2025
[10-Q] FibroGen, Inc Quarterly Earnings Report
Aug 11, 2025
[8-K] FibroGen, Inc Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] FibroGen, Inc SEC Filing
Jul 14, 2025
[8-K] FibroGen, Inc Reports Material Event
28.72M
3.98M
1.58%
31.02%
3.7%
Biotechnology
Pharmaceutical Preparations
United States
SAN FRANCISCO